Clinical Trial Update: Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of elobixibat in combination with cholestyramine for nonalcoholic fatty liver disease and nonalcoholic steatohep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Cholestyramine (cholestyramine)
• Elobixibat (elobixibat)

Snippet

Sponsor: Yokohama City University | Conditions: Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED